A large group of Democratic lawmakers is requesting that the Biden Administration enact a finalized federal rule – #MCIT – that would give seniors on Medicare access to life-saving medical treatments. Get the details. bit.ly/3fcsi7c

Just out in JACC Journals! A gender subgroup analysis of the #Barostim BeAT-HF study shows that, despite having worse baseline symptoms than men, women had similar improvements in symptomatic outcomes (NYHA, 6MHW, QoL) and reductions in NT-proBNP Read: jacc.org/doi/pdf/10.101…

Excited to hear about the first Barostim case at @IHVInews . Thank you Drs. Brett Atwater aysha arshad Christopher O'Connor

Our MDIC's Annual Public Forum is just one week away. We are excited to bring together FDA Medical Devices leaders for a CDRH Town Hall moderated by MDIC Board Chair and Nadim Yared Nadim Yared. Register today and check out the full agenda here: bit.ly/2KLay3w

Amazing…we can have medical devices with multiple positive Level I randomized controlled trials denied Medicare coverage for years, but an Alzheimer’s drug with no clinical outcomes data names its own $56k annual price tag and no one doubts CMSGov will just pay it.

To all the patients, nurses, physicians, engineers, statisticians, regulators, investors and our colleagues at CVRx, who have contributed to making #Barostim available to other patients who need it: THANK YOU ! $CVRX

#OutsmartTheHeart #BAROSTIM @CVRx $CVRx -- Thank you Nasdaq

Thank you Nasdaq for this opportunity to ring the closing bell! #OutsmartTheHeart #Barostim

The landscape of device based therapies in heart failure has seen a major shift in the last years. This is in parts due to a change in the regulatory environment. Our review covers devices for chronic HF, approved and in the pipeline: sciencedirect.com/science/articl… JACC Journals

Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review - ScienceDirect sciencedirect.com/science/articl…

Couldn't agree more with Erik Paulsen & @HenryIMiller: #MCIT is "sound public policy with bipartisan congressional support" & "would promote innovation and streamline access to critical technologies for patients with no other alternatives." issuesinsights.com/2021/08/13/del…

Phenomenal panel with Joann Lindenfeld sharing clinical data, including a gender analysis, Marat Fudim, MD MHS sharing his scientific expertise in this field, and Dr. Brian Howard his personal experience treating heart failure patients ! Looking forward to re-watching the video soon

Congratulations Nanowear for a great feature in the Wall Street Journal !

Congratulations, Amin Yehya, MD, MS, FACC, FHFSA ! Looking forward to working with you at HF Collaboratory!

Great discussion with @FrankMedAlley and Medical Alley

Thanks to the entire AdvaMed team ! Great first day today in DC. Looking forward to the next couple of days in Minnesota !

Always fun to talk about past experiences and lessons we learned. Thank you Scott Whitaker for driving and eliciting a solid conversation !!

Connect with us at #ACC22 this weekend to learn about #Barostim - a new therapy option for #HFrEF patients. #OutsmartTheHeart

Don't miss learning about emerging treatment options at #HeartFailure2022 with Elizabeth Galle, Vice President of Global Clinical Research, and other experts. #OutsmartTheHeart #heartfailure #healthcare #medtech #innovation #CardioTwitter European Society of Cardiology

Thank you Dr Marat Fudim, MD MHS ! Can’t wait to share the exciting results at #THT2023 next month! See you in Boston